Edition:
United States

VIVUS Inc (VVUS.OQ)

VVUS.OQ on NASDAQ Stock Exchange Global Select Market

1.39USD
7 Dec 2016
Change (% chg)

$-0.04 (-2.80%)
Prev Close
$1.43
Open
$1.45
Day's High
$1.45
Day's Low
$1.37
Volume
59,131
Avg. Vol
54,111
52-wk High
$1.84
52-wk Low
$0.92

Select another date:

Wed, Nov 9 2016

BRIEF-Vivus reports Q3 net loss per share $0.09

* Qtrly total revenue $13.4 million versus $24.9 million Source text for Eikon: Further company coverage:

BRIEF-Vivus and Metuchen Pharmaceuticals announce license agreement for commercial rights to Stendra

* VIVUS Inc says additionally, Metuchen will be responsible for royalties due to Mitsubishi Tanabe Pharma corporation based on net sales

BRIEF-Vivus says extends return date of Stendra commercial rights

* Vivus inc says extends return date of stendra commercial rights

BRIEF-Vivus posts qtrly rev $13.8 mln vs $23.0 mln last year

* Qtrly revenue $13.8 million versus $23.0 million Source text for Eikon: Further company coverage:

BRIEF-Vivus says to extend return date of Stendra commercial rights

* Vivus Inc says to extend return date of Stendra commercial rights

BRIEF-Vivus receives notice from Hetero USA that it has filed with U.S. FDA ANDA for generic versions of all strengths of Stendra tablets

* Received notice from Hetero USA that it has filed with U.S. FDA ANDA for generic versions of all strengths of Stendra tablets

Select another date: